{"id":"placebo-of-the-experimental-drug","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3544774","moleculeType":"Small molecule"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as controls in clinical trials to establish the efficacy of an experimental drug by comparison. Any observed effects in placebo groups are attributed to natural disease progression, regression to the mean, or the placebo effect (psychological/expectation-based response). Placebos are essential for blinded trial design to isolate the true therapeutic benefit of the investigational agent.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:28:19.563Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07427680","phase":"PHASE1, PHASE2","title":"Study of TGM-312-SC01 in Healthy Participants and Adults With MASH","status":"RECRUITING","sponsor":"Tangram Therapeutics Plc","startDate":"2026-02","conditions":"Healthy Participants, MASH - Metabolic Dysfunction-Associated Steatohepatitis","enrollment":99},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT06564818","phase":"PHASE3","title":"\"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder\"","status":"RECRUITING","sponsor":"Cybin IRL Limited","startDate":"2024-12-17","conditions":"Major Depressive Disorder","enrollment":220},{"nctId":"NCT07244991","phase":"NA","title":"Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics","status":"RECRUITING","sponsor":"Cardenal Herrera University","startDate":"2026-01-04","conditions":"Dental Caries, Streptococcus Mutans, Tooth Demineralization","enrollment":200},{"nctId":"NCT03410992","phase":"PHASE3","title":"A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2018-02-05","conditions":"Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis","enrollment":435},{"nctId":"NCT07492771","phase":"PHASE1","title":"MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"MicrobiotiX Co., Ltd","startDate":"2026-03","conditions":"Pneumonia - Bacterial, Pseudomonas Aeruginosa Infection","enrollment":18},{"nctId":"NCT05321121","phase":"PHASE4","title":"Dexmedotomidine for Acute Pain Control in Patients With Multiple Rib FracturesRandomized Controlled Trial","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2021-11-12","conditions":"Rib Fractures, Pain, Acute","enrollment":41},{"nctId":"NCT07485764","phase":"PHASE4","title":"Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-06","conditions":"Psoriasis, Plaque Psoriasis, Moderate-to-severe Plaque Psoriasis","enrollment":186},{"nctId":"NCT07339774","phase":"PHASE2","title":"Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2026-03-30","conditions":"Radiotherapy-induced Oral Mucositis","enrollment":128},{"nctId":"NCT07395986","phase":"PHASE2","title":"A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract","status":"ENROLLING_BY_INVITATION","sponsor":"Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.","startDate":"2026-02-10","conditions":"Age Related Cataracts","enrollment":40},{"nctId":"NCT07174947","phase":"PHASE2","title":"SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety","status":"RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2025-10-01","conditions":"Hepatobiliary Malignancy, Fluoxetine, Anxiety Disorders","enrollment":240},{"nctId":"NCT06425159","phase":"PHASE2, PHASE3","title":"A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures","status":"TERMINATED","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2024-06-20","conditions":"Generalized Epilepsy","enrollment":27},{"nctId":"NCT06309966","phase":"PHASE2, PHASE3","title":"Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy","status":"RECRUITING","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2024-05-13","conditions":"Focal Epilepsy","enrollment":390},{"nctId":"NCT06793397","phase":"PHASE3","title":"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder","status":"RECRUITING","sponsor":"Cybin IRL Limited","startDate":"2025-12-10","conditions":"Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder","enrollment":330},{"nctId":"NCT07417124","phase":"PHASE1","title":"Assess the Safety and Tolerability of SNS851 in Healthy Participants","status":"RECRUITING","sponsor":"Oneness Biotech Co., Ltd.","startDate":"2026-03","conditions":"Metabolic Disease","enrollment":52},{"nctId":"NCT06132893","phase":"PHASE2, PHASE3","title":"A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy","status":"RECRUITING","sponsor":"Biohaven Therapeutics Ltd.","startDate":"2024-03-14","conditions":"Focal Epilepsy","enrollment":390},{"nctId":"NCT06994897","phase":"PHASE1","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-08-13","conditions":"Healthy","enrollment":92},{"nctId":"NCT07339631","phase":"PHASE1","title":"Sodium Aescinate for the Treatment of Low Back Pain (LBP) in Adults","status":"RECRUITING","sponsor":"Xijing Hospital","startDate":"2026-03-01","conditions":"Low Back Pain, Paraspinal Muscle, CLBP - Chronic Low Back Pain","enrollment":40},{"nctId":"NCT05029141","phase":"PHASE2","title":"New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2021-09-01","conditions":"Acute Myeloid Leukemia, Refractory Acute Leukemia, Relapsed Adult AML","enrollment":21},{"nctId":"NCT07482644","phase":"NA","title":"Efficacy and Safety of an Essential Oil-Based Product System for Immune Support","status":"NOT_YET_RECRUITING","sponsor":"dōTERRA International","startDate":"2026-05-04","conditions":"Immune System Function, Inflammation","enrollment":40},{"nctId":"NCT07235163","phase":"PHASE1","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"Pfizer","startDate":"2026-04-13","conditions":"Healthy","enrollment":100},{"nctId":"NCT07235150","phase":"PHASE1","title":"A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-12-11","conditions":"Healthy","enrollment":76},{"nctId":"NCT07462819","phase":"PHASE1","title":"A Study to Evaluate the Safety and Tolerability of Intravenous Stemis™ in Elderly Subjects With Mild to Moderate Frailty Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Ji Yan Biomedical Co., Ltd.","startDate":"2026-04","conditions":"Frailty Syndrome","enrollment":12},{"nctId":"NCT07267559","phase":"PHASE4","title":"Dual Orexin Antagonism and Emotion and Affective Processing Study","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-10-01","conditions":"Learning, Cognitive Functioning, Emotional Processing","enrollment":62},{"nctId":"NCT07483346","phase":"PHASE1","title":"IASO-782 in Systemic Lupus Erythematosus","status":"NOT_YET_RECRUITING","sponsor":"Shanghai IASO Biotechnology Co., Ltd","startDate":"2026-04-30","conditions":"SLE - Systemic Lupus Erythematosus","enrollment":20},{"nctId":"NCT06212271","phase":"EARLY_PHASE1","title":"Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-09-25","conditions":"Peripheral Artery Disease","enrollment":24},{"nctId":"NCT05529927","phase":"PHASE2","title":"Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Parnassia Addiction Research Centre","startDate":"2026-05","conditions":"Cocaine Use Disorder","enrollment":204},{"nctId":"NCT05604131","phase":"PHASE2","title":"Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients","status":"RECRUITING","sponsor":"Rohan Dharmakumar","startDate":"2022-11-08","conditions":"Acute Myocardial Infarction Type 1","enrollment":89},{"nctId":"NCT05727189","phase":"PHASE1","title":"A Study of Idazoxan in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Terran Biosciences Australia Pty Ltd","startDate":"2023-02-14","conditions":"Healthy","enrollment":150},{"nctId":"NCT05639946","phase":"PHASE3","title":"Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2023-01-01","conditions":"Spinal Cord Injuries, Neuropathic Pain","enrollment":44},{"nctId":"NCT06137742","phase":"PHASE1, PHASE2","title":"A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2023-11-17","conditions":"Pulmonary Arterial Hypertension","enrollment":96},{"nctId":"NCT07434024","phase":"NA","title":"Erector Spinae Plane Block for Acute Low Back Pain","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-03","conditions":"Non-specific Low Back Pain (NSLBP)","enrollment":300},{"nctId":"NCT07478328","phase":"PHASE2","title":"Chaigui Longmu Ejiao Paste for Ischemic Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Longhua Hospital","startDate":"2026-03-08","conditions":"Ischemic Heart Disease","enrollment":60},{"nctId":"NCT07426640","phase":"NA","title":"Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation","status":"COMPLETED","sponsor":"Al Mouwasat Hospital","startDate":"2021-11-01","conditions":"Premature (Early) Ejaculation","enrollment":150},{"nctId":"NCT04512235","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-11-03","conditions":"AL Amyloidosis","enrollment":281},{"nctId":"NCT04504825","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-08-25","conditions":"AL Amyloidosis","enrollment":125},{"nctId":"NCT07474636","phase":"PHASE2","title":"Efficacy and Safety Study of HS-10542 for IgA Nephropathy","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","startDate":"2026-03-17","conditions":"IgAN, Immunoglobulin A Nephropathy (IgAN), Glomerular Disease","enrollment":90},{"nctId":"NCT04580563","phase":"NA","title":"Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-10-22","conditions":"Septic Shock, Coagulopathy, Disseminated Intravascular Coagulation","enrollment":60},{"nctId":"NCT07474077","phase":"PHASE3","title":"Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2026-05-01","conditions":"Post Partum Haemorrhage","enrollment":88},{"nctId":"NCT06568627","phase":"PHASE3","title":"A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)","status":"RECRUITING","sponsor":"MediWound Ltd","startDate":"2025-06-01","conditions":"Venous Leg Ulcer (VLU)","enrollment":216},{"nctId":"NCT07475065","phase":"PHASE2, PHASE3","title":"The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sebelas Maret","startDate":"2026-03-01","conditions":"Diabetic Polyneuropathy, Peripheral Nervous System Diseases, Peripheral Neuropathy","enrollment":34},{"nctId":"NCT04145674","phase":"PHASE2","title":"A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo","status":"SUSPENDED","sponsor":"Mauro Manconi","startDate":"2022-10-22","conditions":"Restless Legs Syndrome","enrollment":50},{"nctId":"NCT07469228","phase":"PHASE1","title":"A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-08-04","conditions":"Acne Vulgaris","enrollment":1043},{"nctId":"NCT06608277","phase":"PHASE2","title":"Ketamine, SGB and Combination Treatment for TBI","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2025-07-02","conditions":"Posttraumatic Headache, Posttraumatic Stress Disorder","enrollment":175},{"nctId":"NCT07467746","phase":"PHASE2","title":"Research of Traditional Chinese Medicine Oral Preparation of C. Cicadae in the Treatment of ALS Patients With Elevated Plasma Sphingolipids","status":"NOT_YET_RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2026-04","conditions":"Amyotrophic Lateral Sclerosis","enrollment":84},{"nctId":"NCT06206512","phase":"PHASE2","title":"Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder","status":"COMPLETED","sponsor":"Sarfez Pharmaceuticals, Inc.","startDate":"2024-06-15","conditions":"Heart Failure, Overactive Bladder, Incontinence","enrollment":24},{"nctId":"NCT07464431","phase":"PHASE4","title":"Evaluating the Clinical Effectiveness of Sodium Bicarbonate for Critically Ill Patients With Metabolic Acidosis and Acute Kidney Injury","status":"NOT_YET_RECRUITING","sponsor":"Universität Münster","startDate":"2026-03","conditions":"Acute Kidney Injury, Metabolic Acidosis, Critical Illness","enrollment":660},{"nctId":"NCT06720909","phase":"NA","title":"Mindfulness And Placebo for Pain (MAPP) Study","status":"RECRUITING","sponsor":"Arizona State University","startDate":"2025-01-27","conditions":"Chronic Pain","enrollment":45},{"nctId":"NCT04192136","phase":"NA","title":"NAD+ and Exercise in FA","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-09-03","conditions":"Friedreich Ataxia 1","enrollment":75},{"nctId":"NCT06265051","phase":"PHASE2, PHASE3","title":"Tirofiban After Successful MT Recanalization in AIS","status":"COMPLETED","sponsor":"Xiang Luo","startDate":"2024-04-09","conditions":"Acute Ischemic Stroke, Vessel Occlusion","enrollment":1380},{"nctId":"NCT07415954","phase":"PHASE2","title":"A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2026-04-17","conditions":"Diabetes Mellitus, Type 2","enrollment":270},{"nctId":"NCT07462481","phase":"NA","title":"Probiotic Improve Constipation","status":"RECRUITING","sponsor":"Wecare Probiotics Co., Ltd.","startDate":"2026-04-01","conditions":"Constipation","enrollment":80},{"nctId":"NCT07459790","phase":"PHASE2, PHASE3","title":"The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions","status":"RECRUITING","sponsor":"JSC NextGen","startDate":"2023-12-29","conditions":"IC, Hunner Type Interstitial Cystitis, Bladder Pain Syndrome","enrollment":180},{"nctId":"NCT07456670","phase":"PHASE2","title":"Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support","status":"NOT_YET_RECRUITING","sponsor":"Queen's University","startDate":"2026-04-01","conditions":"Preterm Birth, Caffeine, Neonatal Outcomes","enrollment":62},{"nctId":"NCT07462780","phase":"PHASE1","title":"A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Kangzhe Biotechnology Co., Ltd.","startDate":"2026-03","conditions":"Paroxysmal Nocturnal Hemoglobinuria, PNH, Complement-mediated Kidney Disease","enrollment":88},{"nctId":"NCT07462715","phase":"PHASE4","title":"Statins Against Bushfire Smoke","status":"NOT_YET_RECRUITING","sponsor":"Menzies Institute for Medical Research","startDate":"2026-05-01","conditions":"Healthy Adults","enrollment":100},{"nctId":"NCT07087054","phase":"PHASE3","title":"Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen","status":"RECRUITING","sponsor":"Crinetics Pharmaceuticals Inc.","startDate":"2025-11-19","conditions":"Carcinoid Syndrome, Carcinoid, Carcinoid Tumor","enrollment":141},{"nctId":"NCT07377396","phase":"PHASE1","title":"A Study to Assess the Safety of ARGX-124 in Healthy Volunteers","status":"RECRUITING","sponsor":"argenx","startDate":"2026-01-26","conditions":"Healthy Volunteers","enrollment":104},{"nctId":"NCT07258394","phase":"PHASE3","title":"Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus","status":"RECRUITING","sponsor":"Nanjing Medical University","startDate":"2026-01-27","conditions":"Type 1 Diabetes","enrollment":90},{"nctId":"NCT07298395","phase":"PHASE2","title":"Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis","status":"RECRUITING","sponsor":"Enveda Therapeutics","startDate":"2025-12-22","conditions":"Atopic Dermatitis (AD)","enrollment":64},{"nctId":"NCT05342519","phase":"PHASE2","title":"Daily Topical Rapamycin for Vitiligo","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2022-07-28","conditions":"Vitiligo","enrollment":20},{"nctId":"NCT07301255","phase":"PHASE2","title":"ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults","status":"RECRUITING","sponsor":"Enveda Therapeutics","startDate":"2026-01-09","conditions":"Asthma","enrollment":50},{"nctId":"NCT06979180","phase":"NA","title":"A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.","status":"RECRUITING","sponsor":"Papillex Inc.","startDate":"2026-03","conditions":"CIN - Cervical Intraepithelial Neoplasia, CIN 1, CIN 2","enrollment":60},{"nctId":"NCT07226050","phase":"PHASE2","title":"CLF065 for Chronic Pouchitis","status":"RECRUITING","sponsor":"Calibr, a division of Scripps Research","startDate":"2026-03-05","conditions":"Pouchitis","enrollment":20},{"nctId":"NCT07028853","phase":"PHASE3","title":"This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-09-28","conditions":"Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer","enrollment":1000},{"nctId":"NCT06616194","phase":"PHASE3","title":"A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine","status":"RECRUITING","sponsor":"Pfizer","startDate":"2024-11-15","conditions":"Migraine","enrollment":200},{"nctId":"NCT07379580","phase":"PHASE2","title":"A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2026-02-20","conditions":"Mpox (Monkeypox), Smallpox, Orthopoxvirus Infection","enrollment":310},{"nctId":"NCT05726292","phase":"PHASE2","title":"A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-01-06","conditions":"Prostate Cancer, Prostate Adenocarcinoma","enrollment":90},{"nctId":"NCT07445919","phase":"PHASE2","title":"A Clinical Study to Evaluate SM17 for Atopic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"SinoMab BioScience Ltd","startDate":"2026-04-05","conditions":"Atopic Dermatitis","enrollment":200},{"nctId":"NCT04641442","phase":"PHASE2","title":"Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2020-12-18","conditions":"NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations","enrollment":17},{"nctId":"NCT07446361","phase":"NA","title":"A Study to Evaluate the Efficacy of Collagen 16 Serum Alone, Against and as an Adjunct to Radiesse® Biostimulation Procedure in Female Trial Participants With Aged Skin","status":"NOT_YET_RECRUITING","sponsor":"Vichy Laboratoires","startDate":"2026-03-01","conditions":"Wrinkle Appearance, Skin Quality","enrollment":180},{"nctId":"NCT05894239","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2023-09-08","conditions":"Metastatic Breast Cancer","enrollment":230},{"nctId":"NCT05050136","phase":"PHASE2","title":"A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis","status":"RECRUITING","sponsor":"Mirum Pharmaceuticals, Inc.","startDate":"2021-09-22","conditions":"Primary Biliary Cholangitis, PBC","enrollment":260},{"nctId":"NCT07441083","phase":"NA","title":"Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-17","conditions":"Sexual Wellness, Women Health","enrollment":60},{"nctId":"NCT06308952","phase":"PHASE4","title":"Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation","status":"RECRUITING","sponsor":"Duan Chuanzhi","startDate":"2024-07-30","conditions":"Cerebrovascular Event, Stent Stenosis, Ischemic Stroke","enrollment":354},{"nctId":"NCT07445815","phase":"PHASE2","title":"A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody","status":"NOT_YET_RECRUITING","sponsor":"Lanzhou Institute of Biological Products Co., Ltd","startDate":"2026-01-31","conditions":"Rabies (Healthy Volunteers)","enrollment":200},{"nctId":"NCT06494527","phase":"PHASE1","title":"A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in Healthy Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.","startDate":"2024-10-18","conditions":"Safety Issues","enrollment":30},{"nctId":"NCT04336722","phase":"PHASE3","title":"Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Albireo, an Ipsen Company","startDate":"2020-07-08","conditions":"Biliary Atresia","enrollment":254},{"nctId":"NCT05869812","phase":"PHASE2","title":"Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-05-29","conditions":"Atrophy","enrollment":30},{"nctId":"NCT07393958","phase":"NA","title":"Impact of Food Supplementation on Quality of Life in Patients With Endometriosis and Pelvic Pain.","status":"RECRUITING","sponsor":"Arafarma Group, S.A.","startDate":"2026-02-26","conditions":"Endometriosis (Diagnosis)","enrollment":60},{"nctId":"NCT07436130","phase":"NA","title":"Curcumin in Critically Ill Patients With Sepsis","status":"NOT_YET_RECRUITING","sponsor":"Hospital Civil de Guadalajara","startDate":"2026-03-01","conditions":"Sepsis","enrollment":56},{"nctId":"NCT03598309","phase":"PHASE2","title":"Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-06-05","conditions":"Lung Diseases, Lung Cancer, Protection Against","enrollment":19},{"nctId":"NCT07437079","phase":"PHASE1","title":"A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2026-02-24","conditions":"Overweight, Obesity","enrollment":96},{"nctId":"NCT06727396","phase":"PHASE1","title":"A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2024-11-14","conditions":"Healthy Subjects","enrollment":44},{"nctId":"NCT06714006","phase":"PHASE1","title":"Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003","status":"RECRUITING","sponsor":"PYC Therapeutics","startDate":"2025-04-07","conditions":"Autosomal Dominant Polycystic Kidney Disease (ADPKD)","enrollment":116},{"nctId":"NCT07434895","phase":"EARLY_PHASE1","title":"Repeated CBD Administration and Cannabis Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Hannah Harris","startDate":"2026-03","conditions":"Cannabis, Abuse Liability, Experimental Pain in Healthy Human Participants","enrollment":23},{"nctId":"NCT05200936","phase":"PHASE2","title":"Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial","status":"COMPLETED","sponsor":"Definium Therapeutics US, Inc.","startDate":"2021-12-17","conditions":"ADHD, Attention Deficit Disorder","enrollment":53},{"nctId":"NCT07133438","phase":"PHASE4","title":"Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment","status":"RECRUITING","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2025-08-01","conditions":"Retinal Vein Occlusion (RVO)","enrollment":120},{"nctId":"NCT06047262","phase":"PHASE2","title":"Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia","status":"RECRUITING","sponsor":"Marc Donath","startDate":"2024-07-09","conditions":"Diabetes Mellitus, Type 2","enrollment":300},{"nctId":"NCT07433426","phase":"PHASE2","title":"The Impact of Shigellosis and Recommended Treatment in Children","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2026-03-15","conditions":"Diarrhea Infectious, Shigella, Growth & Development","enrollment":700},{"nctId":"NCT07050134","phase":"NA","title":"A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque","status":"ENROLLING_BY_INVITATION","sponsor":"Junbo Ge","startDate":"2025-07-01","conditions":"Hypertriglyceridemia, Carotid Atherosclerotic Plaques","enrollment":40},{"nctId":"NCT07433855","phase":"NA","title":"Efficacy and Safety of Heat-Treated Lactiplantibacillus Plantarum LM1004 on Immune Function","status":"COMPLETED","sponsor":"Soon Chun Hyang University","startDate":"2023-08-31","conditions":"Immune Function","enrollment":120},{"nctId":"NCT05852587","phase":"PHASE1","title":"Xylitol Use for Decolonization of C. Difficile in Patients With IBD","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-08-01","conditions":"Inflammatory Bowel Diseases, Clostridioides Difficile Infection","enrollment":99},{"nctId":"NCT07431476","phase":"PHASE4","title":"Brimonidine 0.33% for Rosacea-Related Facial Erythema","status":"COMPLETED","sponsor":"Istanbul Training and Research Hospital","startDate":"2025-05-01","conditions":"Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)","enrollment":45},{"nctId":"NCT05585606","phase":"PHASE2","title":"Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Silver Creek Pharmaceuticals","startDate":"2022-10-19","conditions":"Acute Ischemic Stroke (AIS)","enrollment":120},{"nctId":"NCT05397652","phase":"PHASE4","title":"Effect of Intravenous Tranexamic Acid on Visual Clarity During Shoulder Arthroscopy in the Beach Chair Position","status":"COMPLETED","sponsor":"Nikola Matejcic","startDate":"2021-05-24","conditions":"Rotator Cuff Tears, Hemorrhage, Surgical, Shoulder Injuries","enrollment":121},{"nctId":"NCT06882772","phase":"PHASE1, PHASE2","title":"Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids","status":"NOT_YET_RECRUITING","sponsor":"University of Nebraska","startDate":"2026-03","conditions":"Congenital Heart Disease (CHD)","enrollment":105},{"nctId":"NCT06080243","phase":"PHASE2","title":"Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2025-03-19","conditions":"Healthy Women of Child Bearing Potential","enrollment":330},{"nctId":"NCT06772753","phase":"PHASE1","title":"Investigation of Psychedelic Effects in Psychoactive Substances","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-02-05","conditions":"Psychedelic Effects in Healthy Volunteers","enrollment":50},{"nctId":"NCT07371169","phase":"NA","title":"Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance","status":"COMPLETED","sponsor":"Uruk University","startDate":"2025-01-01","conditions":"Insulin Resistance, Acanthosis Nigricans","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":76,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo of the experimental drug","genericName":"Placebo of the experimental drug","companyName":"Eurofarma Laboratorios S.A.","companyId":"eurofarma-laboratorios-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}